Suppr超能文献

共价KRASG12C抑制剂的化学蛋白质组学表征

Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor.

作者信息

Wijeratne Aruna, Xiao Junpeng, Reutter Christopher, Furness Kelly W, Leon Rebecca, Zia-Ebrahimi Mohammad, Cavitt Rachel N, Strelow John M, Van Horn Robert D, Peng Sheng-Bin, Barda David A, Engler Thomas A, Chalmers Michael J

机构信息

Discovery Chemistry Research and Technologies and Oncology Research, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, United States.

出版信息

ACS Med Chem Lett. 2018 May 21;9(6):557-562. doi: 10.1021/acsmedchemlett.8b00110. eCollection 2018 Jun 14.

Abstract

The KRASG12C protein product is an attractive, yet challenging, target for small molecule inhibition. One option for therapeutic intervention is to design small molecule ligands capable of binding to and inactivating KRASG12C via formation of a covalent bond to the sulfhydryl group of cysteine 12. In order to better understand the cellular off-target interactions of , a covalent KRASG12C inhibitor, we have completed a series of complementary chemical proteomics experiments in H358 cells. A new thiol reactive probe (TRP) was designed and used to construct a cellular target occupancy assay for KRASG12C. In addition, the thiol reactive probes allowed us to profile potential off-target interactions of with over 3200 cysteine residues. In order to complement the TRP data we designed , an alkyne containing version of , to serve as bait in competitive chemical proteomics experiments. Herein, we describe and compare data from both the TRP and the click chemistry probe pull down experiments.

摘要

KRASG12C蛋白产物是小分子抑制的一个有吸引力但具有挑战性的靶点。治疗干预的一种选择是设计能够通过与半胱氨酸12的巯基形成共价键来结合并使KRASG12C失活的小分子配体。为了更好地理解共价KRASG12C抑制剂的细胞脱靶相互作用,我们在H358细胞中完成了一系列互补的化学蛋白质组学实验。设计了一种新的硫醇反应性探针(TRP),并用于构建KRASG12C的细胞靶点占有率测定。此外,硫醇反应性探针使我们能够分析与超过3200个半胱氨酸残基的潜在脱靶相互作用。为了补充TRP数据,我们设计了一种含炔烃的版本作为竞争性化学蛋白质组学实验的诱饵。在此,我们描述并比较了TRP和点击化学探针下拉实验的数据。

相似文献

1
Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor.共价KRASG12C抑制剂的化学蛋白质组学表征
ACS Med Chem Lett. 2018 May 21;9(6):557-562. doi: 10.1021/acsmedchemlett.8b00110. eCollection 2018 Jun 14.
3
Applications of Reactive Cysteine Profiling.活性半胱氨酸分析的应用。
Curr Top Microbiol Immunol. 2019;420:375-417. doi: 10.1007/82_2018_120.
6
Reactive-cysteine profiling for drug discovery.用于药物发现的反应性半胱氨酸分析。
Curr Opin Chem Biol. 2019 Jun;50:29-36. doi: 10.1016/j.cbpa.2019.02.010. Epub 2019 Mar 18.
7
Reactive chemistry for covalent probe and therapeutic development.用于共价探针和治疗开发的反应性化学。
Trends Pharmacol Sci. 2022 Mar;43(3):249-262. doi: 10.1016/j.tips.2021.12.002. Epub 2022 Jan 6.

引用本文的文献

7
Reactive-cysteine profiling for drug discovery.用于药物发现的反应性半胱氨酸分析。
Curr Opin Chem Biol. 2019 Jun;50:29-36. doi: 10.1016/j.cbpa.2019.02.010. Epub 2019 Mar 18.

本文引用的文献

2
Ras Binder Induces a Modified Switch-II Pocket in GTP and GDP States.Ras Binder 诱导 GTP 和 GDP 状态下的变构 II 口袋。
Cell Chem Biol. 2017 Dec 21;24(12):1455-1466.e14. doi: 10.1016/j.chembiol.2017.08.025. Epub 2017 Oct 12.
4
A Perspective on the Kinetics of Covalent and Irreversible Inhibition.关于共价和不可逆抑制动力学的观点。
SLAS Discov. 2017 Jan;22(1):3-20. doi: 10.1177/1087057116671509. Epub 2016 Oct 5.
6
Identifying compound efficacy targets in phenotypic drug discovery.在表型药物发现中鉴定化合物疗效靶点。
Drug Discov Today. 2016 Jan;21(1):82-89. doi: 10.1016/j.drudis.2015.08.001. Epub 2015 Aug 10.
8
Know your target, know your molecule.了解你的靶点,了解你的分子。
Nat Chem Biol. 2015 Jun;11(6):368-72. doi: 10.1038/nchembio.1813.
9
Drugging the undruggable RAS: Mission possible?靶向不可成药的 RAS:可能完成的任务?
Nat Rev Drug Discov. 2014 Nov;13(11):828-51. doi: 10.1038/nrd4389. Epub 2014 Oct 17.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验